St Jude closes Irvine Biomedical acquisition:
This article was originally published in Clinica
Executive Summary
St Jude Medical has completed its acquisition of Irvine Biomedical, a developer of electrophysiology catheter products to treat cardiac arrhythmias. The Irvine, California-based business will become part of St Jude's new atrial fibrillation division (see Clinica No 1120, p 14).